Welcome to the Research Division of Pathology and Translational Pathobiology
Pathology, derived from the Greek work for suffering (pathos), examines the essential nature of human diseases, including the structural and functional changes that produce them. The field of Pathology is inherently integrative, utilizing the examination of molecular, cellular, and tissue structure and function to understand, diagnose, and treat human disease.
Although Pathology is generally viewed as a medical discipline, individuals with PhDs in Pathology utilize a background in cell and molecular biology coupled with advanced training in disease processes to make critical advancements in the diagnosis and treatment of human disease.
The Research Division in Pathology and Translational Pathobiology includes six tenure-track and two research-track scientists with research programs focused on the major causes of human disability and death, including cardiovascular disease, cancer, and metabolic diseases. With the establishment of a new PhD Program in Pathology and Translational Pathobiology, our department is the only department at LSU Health Shreveport that simultaneously participates in the training of clinicians, clinician scientists, and basic scientists within the same environment.
The Department of Pathology and Translational Pathobiology currently receives over $5.3 million in annual NIH funding*.
Despite our small size (6 tenure track faculty), we currently have more funding than any other department on campus and rank #43 nationally in NIH funding for Pathology Departments.
The department houses one of two CoBRE grants on campus and the only T32 training grant at LSU Health Shreveport.
Our PhD Program
The new PhD program in Pathology and Translational Pathobiology will train and foster exceptional leaders, innovators, and problem solvers in biomedical research that aid in disease prevention by developing effective treatments and cures. Our curriculum couples training in cell and molecular biology, animal models, histology, advanced pathology, and student-specific electives to create a unique training environment centered upon the in-depth understanding of human disease. Students will gain extensive research experience with our Research Division faculty, all of whom have successfully competed for extramural funding.
The ultimate goal of this program is to develop graduates capable of elucidating the mechanisms and origins of human disease at the molecular and/or organismal level and to provide students the opportunity to translate mechanistic insights gained at the bench to clinically relevant applications. The job market for highly skilled individuals with molecular pathology experience extends into a wide variety of sectors, such as academic, biotech, government, and public health.
Louisiana State University Health Shreveport (LSUHS) strives to cultivate a diverse and inclusive culture that supports equity, acceptance, and respect for the differences in others. The institution is committed to achieving excellence in fulfilling its mission by utilizing the rich talents of individuals who contribute different backgrounds, perspectives, and experiences to the work and learning environment and who reflect the varied populations of Louisiana. As such, the institution adopts a definition of diversity that embraces a broad spectrum of human expression and characteristics that include but are not limited to race, ethnicity, gender/gender identity, social and cultural attributes, abilities, sexual orientation, religion, rural or metropolitan background, military or veteran status, and age. In addition, diversity also includes life experiences, record of service, and other talents and personal attributes that enhance the work and learning atmosphere. LSUHS is dedicated to building an inclusive and diverse community through the recruitment, enrollment, hiring, and retention/graduation of students, faculty, staff, and leadership who meet this definition of diversity.